Question 1

What does Progenics Pharmaceuticals do?

Accepted Answer

Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.

Question 2

In what sectors does Progenics Pharmaceuticals operate?

Accepted Answer

Progenics Pharmaceuticals operates in Biotechnology, Health Care, Medical.

Question 3

How many companies has Progenics Pharmaceuticals acquired?

Accepted Answer

Progenics Pharmaceuticals has made 2 acquisitions between 2013-2015, with a total disclosed deal value of $112.0M.

Question 4

What companies are owned by Progenics Pharmaceuticals?

Accepted Answer

Companies acquired by Progenics Pharmaceuticals include EXINI Diagnostics, Molecular Insight Pharmaceuticals.

Question 5

What are Progenics Pharmaceuticals's major acquisitions?

Accepted Answer

Progenics Pharmaceuticals's largest acquisitions include Molecular Insight Pharmaceuticals ($105.0M, 2013), EXINI Diagnostics ($7.0M, 2015).

Question 6

What is Progenics Pharmaceuticals's largest acquisition?

Accepted Answer

Progenics Pharmaceuticals's largest disclosed acquisition is Molecular Insight Pharmaceuticals for $105.0M (2013).

Question 7

What was Progenics Pharmaceuticals's first acquisition?

Accepted Answer

Progenics Pharmaceuticals's first recorded acquisition was Molecular Insight Pharmaceuticals in 2013 for $105.0M.

Question 8

What was Progenics Pharmaceuticals's most recent acquisition?

Accepted Answer

Progenics Pharmaceuticals's most recent acquisition is EXINI Diagnostics, announced October 2015 for $7.0M.

Question 9

What is the average deal size for Progenics Pharmaceuticals acquisitions?

Accepted Answer

The average disclosed deal size for Progenics Pharmaceuticals acquisitions is $56.0M.

Question 10

What is the median deal size for Progenics Pharmaceuticals acquisitions?

Accepted Answer

The median disclosed deal size for Progenics Pharmaceuticals acquisitions is $56.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Progenics Pharmaceuticals spent on acquisitions?

Accepted Answer

Progenics Pharmaceuticals has spent at least $112.0M across its disclosed acquisitions (of 2 total deals; some prices are undisclosed).

Question 12

Which sector has Progenics Pharmaceuticals spent the most on?

Accepted Answer

Progenics Pharmaceuticals has committed the most disclosed capital to Biotechnology companies — about $105.0M across its deals in that sector.

Question 13

What sectors does Progenics Pharmaceuticals usually acquire in?

Accepted Answer

Progenics Pharmaceuticals most frequently acquires companies in Health Diagnostics, Biotechnology, Health Care.

Question 14

In which sector has Progenics Pharmaceuticals made the most acquisitions?

Accepted Answer

Progenics Pharmaceuticals has made the most acquisitions in the Health Diagnostics sector.

Question 15

In which year did Progenics Pharmaceuticals make the most acquisitions?

Accepted Answer

Progenics Pharmaceuticals made the most acquisitions in 2015, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Progenics Pharmaceuticals

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Company Info

Signals & Scores

Acquisitions by Progenics Pharmaceuticals

Key People at Progenics Pharmaceuticals

Explore 200,000+ acquisitions — free

Recent News related to Progenics Pharmaceuticals

FAQs about Progenics Pharmaceuticals

People who checked this page also checked these